Article Details

Lilly lays out ambitious plans for 2023 - BioPharma Dive

Retrieved on: 2022-12-14 17:21:42

Tags for this article:

Click the tags to see associated articles and topics

Lilly lays out ambitious plans for 2023 - BioPharma Dive. View article details on hiswai:

Excerpt

Expected increases in sales and R&D spending will be accompanied by a lengthy clinical and regulatory agenda in diabetes, obesity and Alzheimer's ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up